Literature DB >> 1523099

Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.

Y Cadroy1, D Pierrejean, B Fontan, P Sié, B Boneu.   

Abstract

To determine the influence of aging on the activity of the hemostatic system, we measured the plasma concentration of prothrombin fragments 1+2 (F 1+2), thrombin-antithrombin III complexes (TAT) and fibrin degradation fragments D-dimers (D-D) in 80 healthy subjects with age ranging between 20 and 94 years. All subjects were free of acute or chronic diseases. The three markers (semi-log scale) were positively correlated with age (r greater than 0.7, p less than 0.01). Mean plasma levels of F 1+2, TAT and D-D were two- to five-fold higher in subjects with age greater than or equal to 60 as compared to those less than 60 years (n = 40 in both groups). In these two groups, normal values for F 1+2, TAT and D-D ranged from 0.3-1.2 vs 0.7-2.4 nmol/l, 1.4-2.6 vs 1.9-6.4 micrograms/l and 33-433 vs 312-1180 micrograms/l, respectively. Sex did not influence the results. We conclude that the activity of the hemostatic system is markedly age-dependent, and that elderly subjects display a biological picture of "prethrombotic" state. In addition, for a right clinical use of these three markers, age should be taken into account when normal range is to be established.

Mesh:

Substances:

Year:  1992        PMID: 1523099

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol


  9 in total

Review 1.  Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients.

Authors:  M T Nurmohamed; H R Büller; J W ten Cate
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

2.  Increased prothrombin activation in a patient with congenital afibrinogenemia is reversible by fibrinogen substitution.

Authors:  W Korte; A Feldges
Journal:  Clin Investig       Date:  1994-05

3.  Changes in von Willebrand factor level and von Willebrand activity with age in type 1 von Willebrand disease.

Authors:  N Rydz; J Grabell; D Lillicrap; P D James
Journal:  Haemophilia       Date:  2015-03-10       Impact factor: 4.287

Review 4.  Rational antithrombotic therapy and prophylaxis in elderly, immobile patients.

Authors:  E C van Gorp; D P Brandjes; J W ten Cate
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 4.271

5.  Proteomics Analysis to Identify and Characterize the Biomarkers and Physical Activities of Non-Frail and Frail Older Adults.

Authors:  Ching-Hung Lin; Chen-Chung Liao; Chi-Huang Huang; Yu-Tang Tung; Huan-Cheng Chang; Mei-Chich Hsu; Chi-Chang Huang
Journal:  Int J Med Sci       Date:  2017-02-23       Impact factor: 3.738

6.  Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment.

Authors:  Vibeke Bratseth; Alf-Åge Pettersen; Trine B Opstad; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Thromb J       Date:  2012-08-10

7.  Age-related differences in fibrinolytic parameters in patients with acute traumatic brain injury.

Authors:  Ryuta Nakae; Shoji Yokobori; Yasuhiro Takayama; Kentaro Kuwamoto; Yasutaka Naoe; Hiroyuki Yokota
Journal:  Surg Neurol Int       Date:  2017-09-06

8.  Age-Related Differences in the Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury.

Authors:  Ryuta Nakae; Yu Fujiki; Yasuhiro Takayama; Takahiro Kanaya; Yutaka Igarashi; Go Suzuki; Yasutaka Naoe; Shoji Yokobori
Journal:  Int J Mol Sci       Date:  2020-08-05       Impact factor: 5.923

Review 9.  Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatment.

Authors:  Hugo Ten Cate; Tomasz J Guzik; John Eikelboom; Henri M H Spronk
Journal:  Cardiovasc Res       Date:  2021-07-27       Impact factor: 10.787

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.